GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Probiotix Health PLC (AQSE:PBX) » Definitions » NonCurrent Deferred Liabilities

Probiotix Health (AQSE:PBX) NonCurrent Deferred Liabilities : £0.00 Mil (As of Jun. 2023)


View and export this data going back to 2022. Start your Free Trial

What is Probiotix Health NonCurrent Deferred Liabilities?

Non-Current Deferred Liabilities represents the non-current portion of obligations, which is a liability that usually would have been paid but is now pas due.

Probiotix Health's non-current deferred liabilities for the quarter that ended in Jun. 2023 was £0.00 Mil.

Probiotix Health NonCurrent Deferred Liabilities Historical Data

The historical data trend for Probiotix Health's NonCurrent Deferred Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Probiotix Health NonCurrent Deferred Liabilities Chart

Probiotix Health Annual Data
Trend Dec18 Dec19 Dec20 Dec22
NonCurrent Deferred Liabilities
- - - -

Probiotix Health Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Jun22 Dec22 Jun23
NonCurrent Deferred Liabilities Get a 7-Day Free Trial - - - - -

Probiotix Health NonCurrent Deferred Liabilities Related Terms

Thank you for viewing the detailed overview of Probiotix Health's NonCurrent Deferred Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Probiotix Health (AQSE:PBX) Business Description

Industry
Traded in Other Exchanges
Address
Nostell Business Estate, First Floor Zucchi Suite, Wakefield, GBR, WF4 1AB
Probiotix Health PLC develops probiotics to tackle cardiovascular disease and other lifestyle conditions which are affecting growing numbers of people across the world. The Company has one class of business, in three geographical areas being that of identifying and developing microbial strains, compounds and formulations for use in the nutraceutical industry.

Probiotix Health (AQSE:PBX) Headlines

No Headlines